SPONSOR
Eastern Hepatobiliary Surgery Hospital
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 2, Phase 3
NCT07364305 Phase 2
Recruiting
HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC
ICC
NCT06892925 Phase 2
Recruiting
QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors
Biliary Tract Tumors
NCT07285850 Phase 2, Phase 3
Recruiting
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
HCC - Hepatocellular Carcinoma